Pharmacokinetics of amoxicillin trihydrate in Desert sheep and Nubian goats

被引:20
作者
Elsheikh, HA
Taha, AA
Khalafalla, AE
Osman, IAM
Wasfi, IA
机构
[1] Jordan Univ Sci & Technol, Fac Vet Med, Dept Vet Basic Sci, Irbid 22210, Jordan
[2] Univ Khartoum, Fac Vet Sci, Dept Med Pharmacol & Toxicol, Khartoum N, Sudan
[3] Camelracing Forens Lab, Abu Dhabi, U Arab Emirates
关键词
amoxicillin; bioavailability; breed; goats; pharmacokinetics; sheep;
D O I
10.1023/A:1006318623854
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The pharmacokinetics of amoxicillin were studied in five Desert sheep and five Nubian goats after intravenous (i.v.) or intramuscular (i.m.) administration of a single dose of 10 mg/kg body weight. Following i.v. injection, the plasma concentration-versus-time data were best described by a two-compartment open model. The kinetic variables were similar in both species except for the volume of the central compartment (V-c), which was larger in sheep (p < 0.05). Following i.m. injection, except for the longer half-life time of absorption in goats (p < 0.05), there were no significant differences in other pharmacokinetic parameters between sheep and goats. The route of amoxicillin administration had no significant effect on the terminal elimination half-life in either species. The bioavailability of the drug (F) after i.m. administration was high (> 0.90) in both species. These results indicate that the pharmacokinetics of amoxicillin did not differ between sheep and goats; furthermore, because of the high availability and short half-life of absorption, the i.m. route gives similar results to the i.v. route. Therefore, identical intramuscular and intravenous dose regimens should be applicable to both species.
引用
收藏
页码:507 / 514
页数:8
相关论文
共 50 条
  • [1] Pharmacokinetics of Amoxicillin Trihydrate in Desert Sheep and Nubian Goats
    H.A. Elsheikh
    A.A. Taha
    A.E. Khalafalla
    I.A.M. Osman
    I.A. Wasfi
    Veterinary Research Communications, 1999, 23 : 507 - 514
  • [2] Disposition kinetics of tylosin administered intravenously and intramuscularly in desert sheep and nubian goats
    Taha, AA
    Elsheikh, HA
    Khalafalla, AE
    Osman, IAM
    Abdullah, AS
    VETERINARY JOURNAL, 1999, 158 (03) : 210 - 215
  • [3] THE PHARMACOKINETICS OF SINGLE DOSE INTRAMUSCULAR AMOXICILLIN TRIHYDRATE IN TAMMAR WALLABIES (MACROPUS EUGENII)
    McLelland, David J.
    Rich, Brian G.
    Holz, Peter H.
    JOURNAL OF ZOO AND WILDLIFE MEDICINE, 2009, 40 (01) : 113 - 116
  • [4] Pharmacokinetics of sodium and trihydrate amoxicillin after intravenous and intramuscular administration in llamas (Lama glama)
    Kreil, Veronica E.
    Ambros, Luis
    Montoya, Laura
    Hallu, Ruben
    Rebuelto, Marcela
    Bramuglia, Guillermo
    SMALL RUMINANT RESEARCH, 2012, 102 (2-3) : 208 - 212
  • [5] Pharmacokinetics of amoxicillin in Kilis goats
    Aksoy, Ali Metin
    Kaya, Sezai
    ANKARA UNIVERSITESI VETERINER FAKULTESI DERGISI, 2007, 54 (03): : 171 - 176
  • [6] Comparative pharmacokinetics of salicylate in camels, sheep and goats
    B. H. Ali
    European Journal of Drug Metabolism and Pharmacokinetics, 2003, 28 : 125 - 128
  • [7] Comparative pharmacokinetics of salicylate in camels, sheep and goats
    Ali, BH
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2003, 28 (02) : 125 - 128
  • [8] Comparative pharmacokinetics of intravenous and subcutaneous pantoprazole in sheep and goats
    Fadel, Charbel
    Lebkowska-Wieruszewskac, Beata
    Serih, Firas
    Lisowski, Andrew
    Poapolathep, Amnart
    Giorgi, Mario
    VETERINARY JOURNAL, 2024, 305
  • [9] A comparative study of the pharmacokinetics of isometamidium chloride in sheep and goats
    Wesongah, JO
    Jones, TW
    Kibugu, JK
    Murilla, GA
    SMALL RUMINANT RESEARCH, 2004, 53 (1-2) : 9 - 14
  • [10] Comparative Pharmacokinetics of Intravenous and Subcutaneous Omeprazole in Sheep and Goats
    Serih, Firas
    Fadel, Charbel
    Lebkowska-Wieruszewska, Beata
    Lisowski, Andrzej
    Poapolathep, Amnart
    Giorgi, Mario
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2025, 48 (02) : 86 - 93